17 / 51
Neumol Pediatr 2016; 11 (2): 71 - 75
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
75
Actualización en el tratamiento del asma crónica en niños
P. Montelukast, compared with fluticasone, for control of
asthma among 6- to 14-year-old patients with mild asthma:
the MOSAIC study. Pediatr 2005;116(2):360-9
19. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach
W, Kuna P. Effect of different antiasthmatic treatments
on exercise-induced bronchoconstriction in children with
asthma. J Allergy Clin Immunol 2008;121(2):383-9
20. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.
Addition of long-acting beta2-agonists to inhaled steroids
versus higher dose inhaled steroids in adults and children
with persistent asthma. Cochrane Database Syst Rev
2010(4):CD005533
21. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen
JH, Hultquist C. Budesonide/formoterol maintenance plus
reliever therapy: a new strategy in pediatric asthma. Chest
2006;130(6):1733-43
22. Woodcock A, Bleecker ER, Lotvall J, O’Byrne PM, Bateman
ED, Medley H et al. Efficacy and safety of fluticasone furoate/
vilanterol compared with fluticasone propionate/salmeterol
combination in adult and adolescent patients with persistent
asthma: a randomized trial. Chest. 2013;144(4):1222-9
23. Oliver A, VanBuren S, Allen A, Hamilton M, Tombs L,
Inamdar A, et al. Tolerability of fluticasone furoate/vilanterol
combination therapy in children aged 5 to 11 years with
persistent asthma. Clin Ther 2014;36(6):928-39
24. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
Anti-IgE for chronic asthma in adults and children. Cochrane
Database Syst Rev 2006(2):CD003559
25. Rodrigo GJ, Neffen H, Castro-Rodriguez JA. Efficacy and
safety of subcutaneous omalizumab vs placebo as add-
on therapy to corticosteroids for children and adults with
asthma: a systematic review. Chest 2011;139(1):28-35
26. Vogelberg C, Engel M, Moroni-Zentgraf P, Leonaviciute-
Klimantaviciene M, Sigmund R, Downie J, et al. Tiotropium
in asthmatic adolescents symptomatic despite inhaled
corticosteroids: a randomised dose-ranging study. Respir
Med 2014;108(9):1268-76
27. Vogelberg
C,
Moroni-Zentgraf
P,
Leonaviciute-
Klimantaviciene M, Sigmund R, Hamelmann E, Engel M et al.
A randomised dose-ranging study of tiotropium Respimat®
in children with symptomatic asthma despite inhaled
corticosteroids. Respir Res 2015;16:20
28. Soler-Escoda JM, Alonso RE. Inmunoterapia en patología
alérgica pediátrica. Pediatr Integral 2005;IX(8):575-90
29. Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold
I, Nelson HS. Sublingual immunotherapy: a comprehensive
review. J Allergy Clin Immunol 2006;117(5):1021-35
30. Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-
Cuervo C, Chelladurai Y et al. Sublingual immunotherapy for
the treatment of allergic rhinoconjunctivitis and asthma: a
systematic review. JAMA 2013;309(12):1278-88